期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗幽门螺杆菌治疗用于难治性特发性血小板减少性紫癜的疗效观察 被引量：3

暂未订购
导出
摘要 目的探讨根除幽门螺旋杆菌(Hp)在难治性特发性血小板减少性紫癜(ITP)治疗中的作用。方法 72例符合难治性ITP诊断标准且经C14呼气试验Hp阳性的患者纳入试验。在根除Hp治疗前及结束后,定期复查血小板计数,并在治疗结束后进行评估。结果 72例患者治疗后2周、4周、3个月血小板计数均呈递增趋势。基本治愈23例,缓解19例,进步16例,无效14例,总有效率80.6%。结论根治Hp可以作为治疗合并Hp感染的难治性ITP患者行之有效的非免疫抑制治疗方法之一。
作者 李琳洁 许能文 裘红英 刘伟红 金炀缙 赵敏蕾 陈延杰 陈玉 张隽瑜
机构地区 丽水市中心医院
出处 《现代实用医学》 2013年第4期416-417,共2页 Modern Practical Medicine
基金 浙江省丽水市重点科技计划项目(200961-1)
关键词 紫癜 血小板减少 特发性 血小板计数 螺杆菌 幽门 根除
分类号 R558.2 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献10

  • 1Fogarty PF. Chronic immune thrombo-cytopenia in adults: epidemiology and cli-nical presentation[J].Hematol Oncol ClinNorth Am,2009,23(6):1213-1221.
  • 2Terrell DR, Beebe LA, Vesely SK, et al.The incidence of immune thromboeytope-nic purpura in children and adults: a criti-cal review of published reports[J].Am JHematol,2010,85(3):174-180.
  • 3Kojouri K, Vesely SK, Terrell DR, et al.Splenectomy for adult patients with idio-pathic thrombocytopenic purpura: a syste-matic review to assess long-term plateletcount responses, prediction of response,and surgical complications[J].Blood,2004,104(9):2623-2634.
  • 4陈方平,付斌.难治性特发性血小板减少性紫癜规范化诊断和治疗[J].临床血液学杂志,2010,23(4):385-387. 被引量：15
  • 5Gasbarrini A, Franceschi F, TartaglioneR, et al. Regression of autoimmune throm-bocytopenia after eradication of helicoba-cter pylori [J]. Lancet, 1998,352(9131):878.
  • 6陆再英.内科学[M].6版.北京:人民卫生出版社.2004:175
  • 7Takahashi T, Yujiri T, Shinohara K, et al.Molecular mimicry by Helicobacter pylo-ri CagA protein may be involved in thepathogenesis of H.pylori-associatedchronicidiopathic thrombocytopenic pur-pura [J].Br J Haematol,2004,124(1):91-96.
  • 8Franchini M, Veneri D. Helicobacter pylo-ri infection and immune thrombocytope-nic purpura [J]. Helicobacter, 2004,9 (4):342-346.
  • 9Fujimura K, Kuwana M, Kurata Y,et al. Iseradication therapy useful as the first lineof treatment in Helicobacter pylori-posi-tive idiopathic thrombocytopenic purpur-a. Analysis of207 eradicated chronic ITPcases in Japan [J]. Int J Hematol,2005,81(2):162-168.
  • 10Shigeto N, Shimizu S. Eradication ofheli-obacter pylori for idiopathic thrombo-cytopenic purpura [J]. Nippon ShokakibyoGakai Zasshi,2004,101(6):598-608.

二级参考文献14

  • 1RODEGHIERO F,STASI R,GERNSHEIMER T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,113:2386-2393.
  • 2GUPTA R,SOUPIR C P,JOHARI V,et al.Myelodysplastic syndrome with isolated deletion of chromosome 20q:an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation[J].Br J Haematol,2007,139:265-268.
  • 3VESELY S K,PERDUE J J,RIZVI M A,et al.Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy:a systematic review[J].Ann Intern Med,2004,140:112-120.
  • 4BURZYNSKI J.New options after first-line therapy for chronic immune thrombocytopenic purpura[J].Am J Health Syst Pharm,2009,66:S11-21.
  • 5DIERICKX D,VERHOEF G,VAN HOOF A,et al.Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura:a Belgian retrospective multicentric study[J].J Intern Med,2009,266:484-491.
  • 6COOPER N,STASI R,CUNNINGHAM-RUNDLES S,et al.The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura[J].Br J Haematol,2004,125:232-239.
  • 7PENALVER F J,JIMENEZ-YUSTE V,ALMAGRO M,et al.Rituximab in the management of chronic immune thrombocytopenic purpura:an effective and safe therapeutic alternative in refractory patients[J].Ann Hematol,2006,85:400-406.
  • 8STASI R,PAGANO A,STIPA E,et al.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura[J].Blood,2001,98:952-957.
  • 9BENNETT C M,ROGERS Z R,KINNAMON D D,et al.Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura[J].Blood,2006,107:2639-2642.
  • 10PASA S,ALTINTAS A,CIL T,et al.The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura[J].J Thromb Thrombolysis,2009,27:329-333.

共引文献16

同被引文献41

引证文献3

二级引证文献8

现代实用医学
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部